Replies to post #310764 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

For late breaking abstracts (at SNO), there needs to be a shell abstract in June without results, and the completed abstract by September 1, with results. Maybe there is some exception, but the rules say no exceptions to the Sept. 1 deadline. The details given for the abstract say one will be able to assess whether autologous DC therapy is an effective treatment to increase GBM survival. It’s hard to know how’d they be able to claim that without results.